Detalles de la búsqueda
1.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Cell
; 187(12): 2919-2934.e20, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38761800
2.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078508
3.
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Nature
; 594(7864): 553-559, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33971664
4.
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial.
Blood
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643491
5.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37832030
6.
Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.
Rheumatology (Oxford)
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483276
7.
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.
Br J Dermatol
; 190(4): 559-564, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931161
8.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142374
9.
Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
Br J Haematol
; 202(1): 48-53, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951278
10.
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.
Blood
; 137(2): 203-215, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33443553
11.
Rare central nervous system lymphomas.
Br J Haematol
; 197(6): 662-678, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292959
12.
Population-based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large-cell lymphoma using Public Health England data.
Br J Haematol
; 196(4): 932-938, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664265
13.
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Br J Haematol
; 199(4): 507-519, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945164
14.
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.
Rheumatology (Oxford)
; 61(7): 2783-2791, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34718430
15.
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
BMC Cancer
; 22(1): 971, 2022 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36088292
16.
Montelukast and neuropsychiatric events - a sequence symmetry analysis.
J Asthma
; 59(12): 2360-2366, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34979844
17.
Correlates of GLA family adjuvants' activities.
Semin Immunol
; 39: 22-29, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30366662
18.
Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
Br J Haematol
; 195(4): 561-570, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34368948
19.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308
20.
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
Br J Haematol
; 190(3): 394-404, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232989